论文部分内容阅读
有研究表明，红细胞生成素（ＥＰＯ）在治疗慢性肾功能衰竭（ＣＲＦ）贫血的同时，还能增强吞噬细胞活性，影响细胞免疫和体液免疫功能。ＥＰＯ对 ＩｇＧ亚类的影响及意义，尚未见报道。为此，我们测定了ＥＰＯ治疗组和非治疗组ＣＲＦ患者血清 ＩｇＧ及其亚类含量，并与健康人
Studies have shown that erythropoietin (EPO) in the treatment of chronic renal failure (CRF) anemia, but also enhance the activity of phagocytic cells, affecting cellular and humoral immune function. The impact and significance of EPO on IgG subclasses have not been reported yet. To this end, we measured the levels of serum IgG and its subclasses in CRF patients treated with or without EPO and compared with those of healthy individuals